The Irish Medtech Association acknowledged John O’Dea’s 25 years in the industry with the Outstanding Contribution to Medtech Award 2016. This award recognises an individual who has made a significant contribution to the development, growth and success of the medtech sector in Ireland. The recipient is selected by the Irish Medtech Association board, with the support of Enterprise Ireland and IDA Ireland, in acknowledgement of a person’s contribution to the overall sector rather than to any one company or organisation.
Irish Medtech Association Director Sinead Keogh, said: “John O’Dea is a great ambassador for Ireland’s Medtech community. While he began his career as an engineer working in multinationals Digital Equipment and Puritan Bennett, he has become known as a champion for entrepreneurs, with a passion for building linkages across academic and clinical communities. His business Caradyne was acquired by Respironics in 2004 and he has been CEO of Crospon which he founded in Galway 10 years ago. Setting-up and running his own businesses may be time consuming but he continues to generously give his time to share his experience as the Chairman of the External Advisory Board for BioInnovate Ireland, as well as a Special Advisor to the SFI CURAM Centre for Research in Medical Devices, as well as the wider Medtech community.”
On receiving his award CEO Crospon John O’Dea highlighted the importance of supporting new businesses: “Ten years on at my own start-up, Crospon, I only feel we are getting going. Building a device, building the clinical evidence base, it is a long journey. Here in Ireland the landscape for device start-ups continues to greatly improve with such initiatives as BioInnovate, Curam and the Health Innovation Hub providing fertile ground for new enterprise. I have through my involvement down the years with the Irish Medtech Association and its predecessor, the Irish Medical Devices Association, always looked to champion start-ups.”
“As we further develop this industry, we need to look to how companies can traverse the long journey to market. In particular, we need alternatives to venture capital funding and longer term sources of funding to allow us build companies that can thrive and create employment. What keeps us going, as entrepreneurs in this industry is the shared belief that engineers and clinicians working together can change the way medicine is practiced. This is what makes working in this industry special, and I am very appreciative for the recognition for my role in this sector with the Outstanding Contribution to Medtech Award 2016.”